
The purpose of this study was to characterize the CRSsNP endotype by identifying and validating non-invasive proteomic biomarkers. Two proteins were significantly downregulated including scavenger receptor class F member 2 (SCARF2) and P-selectin. Proteomic analysis of CRSsNP and control mucus has confirmed known and revealed novel disease-associated proteins that could potentially serve as a new biosignature for CRSsNP.
Like
Save
Share